HIV Monoclonal Antibodies: A New Opportunity to Further Reduce Mother-to-Child HIV Transmission

Yegor Voronin(Global HIV Vaccine Enterprise), W. F. Snow(Global HIV Vaccine Enterprise), Barney S. Graham(National Institutes of Health), Jeffrey T. Safrit(Elizabeth Glaser Pediatric AIDS Foundation), Coleen K. Cunningham(Duke Medical Center), Lynne Mofenson(Elizabeth Glaser Pediatric AIDS Foundation), Pontiano Kaleebu(Uganda Virus Research Institute), Mary Glenn Fowler(Johns Hopkins University), Elizabeth J. McFarland(University of Colorado Anschutz Medical Campus)
PLoS Medicine
April 8, 2014
10.1371/journal.pmed.1001616
Cited by 34

Related Papers

Cryo-EM structure of the 2019-nCoV spike in the prefusion conformation
|Science|2020|9.8k
Clinical manifestations, risk factors, and maternal and perinatal outcomes of coronavirus disease 2019 in pregnancy: living systematic review and meta-analysis
|BMJ|2020|2.4k
SARS-CoV-2 mRNA vaccine design enabled by prototype pathogen preparedness
|Nature|2020|1.7k
Intrapartum and neonatal single-dose nevirapine compared with zidovudine for prevention of mother-to-child transmission of HIV-1 in Kampala, Uganda: HIVNET 012 randomised trial
|The Lancet|1999|1.7k
Immunogenicity and structures of a rationally designed prefusion MERS-CoV spike antigen
|Proceedings of the National Academy of Sciences|2017|1.2k